Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

New cancer drugs often cause skin and nail problems.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

Chemotherapy reduces splenic melanin in mice.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

Suppressing ODC activity reduces tumor growth in hair follicles.

A rare skin cancer was correctly diagnosed after surgery, highlighting the need for careful examination and follow-up.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

UTX is important for skin health and its loss can lead to skin issues, especially in females.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.